Valeant Ruling May Pave Way For Patent-Based FCA Suits
In Silbersher v. Valeant Pharmaceuticals International Inc., a generic-drug maker challenged the validity of Valeant's patent before the Patent Trial and Appeal Board and won, with a finding that Valeant got...To view the full article, register now.
Already a subscriber? Click here to view full article